AI Science Tracker
EN

Explainable regression guides laboratory tests of malaria candidates

King's College London; London School of Economics and Political Science; London School of Hygiene and Tropical Medicine; University College London · 22 Nov 2023 · medicine

Discovery

Explainable regression guides laboratory tests of malaria candidates

Source check: Source checked. Not independent scientific confirmation.

Finding: Piecewise-regression models learned activity relationships from 386 Open Source Malaria compounds and prioritized fragments for a commercial-library search. Researchers tested 22 selected compounds and followed three in concentration-response and human-cell cytotoxicity assays. A02 and A10 showed qualitatively consistent parasite-growth inhibition across the initial screen and follow-up curves. The third candidate, A22, has an unresolved screen-versus-curve discrepancy. These are modest-potency laboratory starting points, without established treatment efficacy or secure strongest-hit and selectivity claims.

Technology: modSAR supervised piecewise linear regression; SHAP

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The fitted model learns fingerprint breakpoints and region-specific activity coefficients, prioritizing fragments and predicting activity to narrow 934 commercial compounds to 97, then 22 after additional chemical filters.
Test and result
Twenty-two model-prioritized commercial compounds underwent direct parasite-growth screening. A02 and A10 showed consistent qualitative inhibition across screen and follow-up; the paper additionally reports A22 concentration-response and human-cell cytotoxicity measurements, with its conflicting screen result retained.
Limitation / still unknown
Clinical efficacy, mechanism and independent replication are unestablished. A 22 shows only 18.6% mean inhibition at 10 micromolar in the initial screen despite a later reported IC 50 of 8.29 micromolar; the discrepancy is unresolved, so exact potency and selectivity are not represented as secure estimates.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://eprints.lse.ac.uk/121101/1/Cardoso_Silva_optimisation_based_modelling_published.pdf · https://doi.org/10.1016/j.artmed.2023.102700

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary author-institution-deposited published version read through indexed PDF text for Methods, fragment-to-test selection, experimental results and front metadata; matched third-party journal-PDF figure inspected separately, with access distinction and numerical inconsistency retained. Current PubMed notice metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.